Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: An electron microscopy study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 3, 2008, Pages 379-388

  Maia, Maurício ^a   Penha, Fernando Marcondes ^a   Farah, Michel Eid ^a   Dib, Eduardo ^a   Príncipe, André ^a   Lima Filho, Acácio A S ^a   Magalhães Jr , Octaviano ^a   Freymüller, Edna ^a   Rodrigues, Eduardo B ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Benzyl alcohol; Chromovitrectomy; Electron microscopy; Kenalog; Preservative; Retina pharmacotherapy; Toxicity; Triamcinolone acetonide

Indexed keywords

BALANCED SALT SOLUTION; BENZYL ALCOHOL; TRIAMCINOLONE ACETONIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG ADMINISTRATION ROUTE; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; MICROSCOPY; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RABBIT; RETINA INJURY; STAGING; SUBRETINAL DRUG ADMINISTRATION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; INJECTIONS; MICROSCOPY, ELECTRON, TRANSMISSION; PRESERVATIVES, PHARMACEUTICAL; RABBITS; RETINA; TRIAMCINOLONE ACETONIDE; VEHICLES; VITRECTOMY;

EID: 39149134633     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0718-y     Document Type: Article

References (39)

1. Jonas JB, Kreissig I, Degenring R (2005) Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 24:587-611
2. Rodrigues EB, Meyer CH, Kroll P (2005) Chromovitrectomy: A new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 243:291-293
3. Shah GK, Rosemblat BJ, Smith M (2004) Internal limiting membrane peeling using TA: Histopathologic confirmation. Am J Ophthalmol 138:656-657
4. Karacorlu M, Ozdemir H, Arf Karacorlu S (2005) Does intravitreal triamcinolone acetonide-assisted peeling of the internal limiting membrane effect the outcome of macular hole surgery? Graefes Arch Clin Exp Ophthalmol 243:754-757
5. Maia M, Haller JA, Pieramici DJ, Margalit E, de Juan E Jr, Farah ME, Lakhanpal RR, Au Eong KG, Guven D, Humayun MS (2004) Retinal pigment epithelium abnormalities after internal limiting membrane peeling guided by indocyanine green staining. Retina 24:157-160
6. Yeung CK, Chan KP, Chiang SW, Pang CP, Lam DS (2003) The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 44:5293-5300
7. Avci R, Kaderli B (2006) Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates. Graefes Arch Clin Exp Ophthalmol 244:28-35
8. Ramezani A, Entezari M, Moradian S, Tabatabaei H, Kadkhodaei S (2006) Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 244:1601-1606
9. Hida T, Chandler D, Arena JE, Machemer R (1986) Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 101:190-195
10. Kertes PJ, Coupland SG (2005) The use of subretinal triamcinolone acetonide in the management of neovascular age-related macular degeneration: A pilot study. Can J Ophthalmol 40:573-584
11. Beeley NR, Rossi JV, Mello-Filho PA, Mahmoud MI, Fujii GY, de Juan E Jr, Varner SE (2005) Fabrication, implantation, elution, and retrieval of a steroid-loaded polycaprolactone subretinal implant. J Biomed Mater Res A 73:437-444
12. Albini TH, Abd-El-Barr MM, Carvounis PE, Iyer MN, Lakhanpal RR, Pennesi ME, Chevez-Barrios P, Wu SM, Holz ER (2007) Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes. Invest Ophthalmol Vis Sci 48:390-395
13. Dierks D, Lei B, Zhang K, Hainsworth DP (2005) Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina. Arch Ophthalmol 123:1563-1569
14. McGee DH, Dembinska O, Gruebbel MM (2005) Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits. Int J Toxicol 24:419-425
15. Kozak I, Cheng L, Mendez T, Davidson MC, Freeman WR (2006) Evaluation of the toxicity of subretinal triamcinolone acetonide in the rabbit. Retina 26:811-817
16. Macky TA, Helmy D, El Shazly N (2007) Retinal toxicity of triamcinolone's vehicle (benzyl alcohol): An electrophysiologic and electron microscopic study. Graefes Arch Clin Exp Ophthalmol 245:817-824
17. Hernaez-Ortega MC, Soto-Pedre E (2004) A simple and rapid method for purification of TA suspension for intravitreal injection. Ophthalmic Surg Laser Imaging 35:350-351
18. Garcia-Arumi J, Boixadera A, Giralt J, Martinez-Castillo V, Gomez-Ulla F, Corcostegui B, Garcia-Arumi E (2005) Comparison of different techniques for purification of TA suspension for intravitreal use. Br J Ophthalmol 89:1112-1114
19. Penha F, Maia M, Farah ME, Príncipe AH, Freymüller E, Maia A, Magalhães Jr O, Smith RL (2007) Effects of subretinal injection of indocyanine green, trypan blue and glucose in rabbit eyes. Ophthalmology 114(5):899-908
20. Maia M, Penha F, Rodrigues EB, Príncipe A, Dib E, Meyer CH, Freymuller E, Moraes N, Farah ME (2007) Effects of subretinal injection of patent blue and trypan blue in rabbits. Curr Eye Res 32(4):309-317
21. Maia M, Kellner L, de Juan E Jr, Smith R, Farah ME, Margalit E, Lakhanpal RR, Grebe L, Au Eong KG, Humayun MS (2004) Effects of indocyanine green injection over the retinal surface and into the subretinal space in rabbits. Retina 24:80-91
22. Modarres M, Parvaresh MM, Peyman GA (1998) Accidental subretinal injection of triamcinolone acetonide. Ophthalmic Surg Lasers 29:935-938
23. Fukukita M, Sasoh M, Matsubara H, Furuta M, Okawa C, Ito Y, Wakitani Y, Uji Y (2007) Triamcinolone acetonide remaining on the fovea after successful macular hole closure. Retina 27:122-123
24. Van de Moere A, Sandhu SS, Kak R, Mitchell KW, Talks SJ (2005) Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin. Ophthalmology 112:1896-903
25. Felt-Baeyens O, Eperon S, Mora P, Limal D, Sagodira S, Breton P, Simonazzi B, Bossy-Nobs L, Guex-Crosier Y, Gurny R (2006) Biodegradable scleral implants as new triamcinolone acetonide delivery systems. Int J Pharm 322:6-12
26. Kato A, Kimura H, Okabe K, Okabe J, Kunou N, Ogura Y (2004) Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant. Invest Ophthalmol Vis Sci 45:238-244
27. Kim H, Csaky KG, Gravlin L, Yuan P, Lutz RJ, Bungay PM, Tansey G, DE Monasterio F, Potti GK, Grimes G, Robinson MR (2006) Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration. Retina 26:523-530
28. Ruiz-Moreno JM, Montero JA, Bayon A, Rueda J, Vidal M (2007) Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res 84:342-348
29. Yu SY, Damico FM, Viola F, D'Amico DJ, Young LH (2006) Retinal toxicity of intravitreal triamcinolone acetonide: A morphological study. Retina 26:531-536
30. Zemel E, Loewenstein A, Lei B, Lazar M, Perlman I (1995) Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity. Invest Ophthalmol Vis Sci 36:1875-1884
31. Szurman P, Kaczmarek R, Spitzer MS, Jaissle GB, Decker P, Grisanti S, Henke-Fahle S, Aisenbrey S, Bartz-Schmidt KU (2006) Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells. Exp Eye Res 83:584-592
32. Szurman P, Kaczmarek R, Jaissle GB, Grisanti S, Luke M, Spitzer MS, Heide PE, Bartz-Schmidt KU (2006) Influence of different purification techniques on triamcinolone yield and particle size spectrum. Graefes Arch Clin Exp Ophthalmol 245:698-696
33. Tu AH, Equi R, Arai SI, Sadda S, Varner S, Rao N, de Juan E Jr (2004) Subretinal delivery of triamcinolone in a laser-induced primate model of choroidal neovascularization: Angiographic and histopathological study. Invest Ophthalmol Vis Sci 45:E-Abstract 5055
34. Kai W, Yanrong J, Xiaoxin L (2006) Vehicle of TA is associated with retinal toxicity and transient increase of lens density. Graefes Arch Clin Exp Ophthalmol 244:1152-1159
35. Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kuppermann BD (2006) Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 47:722-728
36. Walter P, Luck C, Sickel W (1999) Antibiotics and light responses in superfused bovine retina. Cell Mol Neurobiol 19:87-92
37. Morrison VL, Koh HJ, Cheng L, Bessho K, Davidson MC, Freeman WR (2006) Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina 26:339-344
38. Hetherington NJ, Dooley MJ (2000) Potential for patient harm from intrathecal administration of preserved solutions. Med J Aust 173:141-143
39. Shaikh S, Ho S, Engelmann LA, Klemann SW (2006) Cell viability effects of triamcinolone acetonide and preservative vehicle formulations. Br J Ophthalmol 90:233-236